Brachytherapy of intra ocular tumors using ‘BARC I-125 Ocu-Prosta seeds’: An Indian experience
Open Access
- 1 February 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Indian Journal Of Ophthalmology
- Vol. 62 (2) , 158-162
Abstract
Aim: To report our experience of brachytherapy using ‘BARC I-125 Ocu-Prosta seeds’ for the management of intraocular tumors with regard to tumor control, globe preservation visual outcome, and patient survival at Sankara Nethralaya, Chennai, India between September 2003 and May 2011. Materials and Methods: We reviewed records of 35 eyes of 35 patients who underwent ophthalmic brachytherapy between September 2003 and May 2011. Twenty-one cases had choroidal melanoma, nine had childhood retinoblastoma, two had adult-onset retinoblastoma, and there were one case each of vasoproliferative tumor, retinal angioma, and ciliary body melanoma. Brachytherapy was administered using a 15- or 20-mm gold plaque with or without a notch. Brachytherapy was the primary treatment modality in all tumors other than retinoblastoma, wherein brachytherapy was done post chemoreduction for residual tumor. Results: For choroidal melanomas, the mean radiation dose was 68.69 ± 15.07 (range, 47.72-94.2) Gy. The eye salvage rate was 13/20 (65%) and tumor control rate was 16/20 (80%) at an average follow-up of 24.43 ± 24.75 (range, 1.5-87.98) months. For retinoblastoma, the mean dose was 45.85 ± 3.90 (range, 39.51-50.92) Gy. The eye salvage rate and tumor control rate was 5/6 (83.3%) at an average follow-up of 38.36 ± 31.33 (range, 4.14-97.78) months. All eyes with retinoblastoma needed additional focal therapy for tumor control and eye salvage. Conclusion: The results of this retrospective study confirms that the use of ‘BARC I-125 Ocu-Prosta seeds’ in episcleral plaques to treat intraocular tumors offers a viable option for the management of intraocular cancers.Keywords
This publication has 11 references indexed in Scilit:
- Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in IndiaIndian Journal Of Ophthalmology, 2012
- Studies on the production and quality assurance of miniature 125I radioactive sources suitable for treatment of ocular and prostate cancersApplied Radiation and Isotopes, 2006
- Ruthenium Brachytherapy for Uveal Melanoma, 1979–2003Survival and Functional Outcomes in the Swedish PopulationOphthalmology, 2005
- Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years’ experience with beta-rays)American Journal of Ophthalmology, 2004
- The American Brachytherapy Society recommendations for brachytherapy of uveal melanomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- A novel approach for the adsorption of iodine-125 on silver wire as matrix for brachytherapy source for the treatment of eye and prostate cancerApplied Radiation and Isotopes, 2002
- Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanomaGraefe's Archive for Clinical and Experimental Ophthalmology, 2000
- Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanomaOphthalmology, 1999
- Radiation therapy for choroidal melanomaSurvey of Ophthalmology, 1997
- The treatment of ophthalmic tumours with low-energy sourcesBritish Journal of Radiology, 1976